Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF)

Q: What does CUSIP G39342103 represent in this 13F holders report?

CUSIP G39342103 is the security identifier for CORBF - Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held CORBF - Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share in Q2 2022?

24 institutional investors reported CORBF - Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share for Q2 2022. Use the holders table for investor-level position and value details.

CUSIP: G39342103

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Debt / Ordinary Shares, par value $0.0001 per share
Market price (% of par): 296.02%
Total 13F principal: $11,720,823
Principal change: +$769,498
Total reported market value: $34,694,000
Number of holders: 24
Value change: +$188,969
Number of buys: 13
Number of sells: 12

Quarterly Holders Quick Answers

What is CUSIP G39342103?
CUSIP G39342103 identifies CORBF - Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP G39342103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CORBF - Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF) as of Q2 2022

As of 30 Jun 2022, Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF) was held by 24 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $11,720,823 in principal (par value) of the bond. The largest 10 bondholders included Oasis Management Co Ltd., RENAISSANCE TECHNOLOGIES LLC, Man Group plc, BlueCrest Capital Management Ltd, Quinn Opportunity Partners LLC, NATIXIS ADVISORS, L.P., BANK OF AMERICA CORP /DE/, FourWorld Capital Management LLC, MORGAN STANLEY, and BOOTHBAY FUND MANAGEMENT, LLC. This page lists 24 institutional bondholders reporting positions for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price (% of par)	Principal	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Q2 2022 holders

Holder diff

-1

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.